Aaron S Mansfield

55PUBLICATIONS
317CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Apr 30, 2026
Early ctDNA Stratifies Survival in Locally Advanced and Oligometastatic Lung Cancer Treated with Radiotherapy.

|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Mar 11, 2026
Point of care molecular cancer diagnostics.

Seemesh Bhaskar, Saurabh Umrao, Han Keun Lee

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Feb 12, 2026
Functional genomics identifies therapeutic options, biomarkers, and resistance mechanisms for high-grade gliomas.

Wan-Hsin Lin, Farhad Kosari, James B Smadbeck

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

Pageof 10

Frequent Collaborators

6 joint publications

Haidong Dong

5 joint publications

Sean S Park

3 joint publications

Stephen V Liu

3 joint publications

Anne S Tsao